Search
parecoxib (Dynastat)
In pipeline. Mid 2002. 1st injectable COX-2 inhibitor. FDA approval rejected in 2005. [3]
Prodrug of valdecoxib (Bextra).
Manufacturer: Pharmacia.
Interactions
drug interactions
drug adverse effects (more general classes)
monitor with non steroidal anti-inflammatory agents (NSIADs)
General
cyclooxygenase-2 (COX-2) specific inhibitor
Properties
INHIBITS: cyclooxygenase-2
Database Correlations
PUBCHEM correlations
References
- Prescriber's Letter 8(11):61 2001
- Journal Watch 25(6):52, 2005
- FDA rejects parecoxib, only injectable COX-2 inhibitor
http://www.medscape.com/viewarticle/538344